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Summary  Asymptomatic  carriage  of  methicillin-resistant  Staphylococcus  aureus
(MRSA)  can  predispose  the  host  to  a  wide  range  of  infections.  To  inform  public  health
strategies,  this  study  sought  to  determine  the  prevalence  and  the  phenotypic  and
genotypic  characteristics  of  MRSA  from  nasal  swabs  of  health  care  workers  (HCWs)
and  other  healthy  individuals  in  Jordan.  Overall,  716  nasal  swabs  were  collected
from  297  HCWs,  141  adults  and  278  children  in  the  community.  MRSA  was  recovered
from  56  (7.8%)  nasal  swabs,  which  represented  carriage  rates  of  10.1%,  4.3%  and
7.2%  among  HCWs,  adults  and  children,  respectively.  The  MRSA  isolates  were  resis-
tant  to  oxacillin  (100%),  erythromycin  (42.8%),  tetracycline  (37.5%),  clindamycin
(5.3%),  fucidin  (5.3%),  and  ciproﬂoxacin  (3.5%).  A  total  of  17  different  spa  types
belonging  to  eight  different  clonal  complexes  (CCs)  were  identiﬁed.  All  isolates  were
mecA  positive,  and  mecC-MRSA  was  not  detected.  Analysis  of  the  staphylococcal  cas-
sette  chromosome  mec  (SCCmec) elements  revealed  that  the  majority  (54;  96.4%)
of  the  samples  harbored  the  smaller  type  IV  and  V  elements  (the  most  common  were
SCCmec  IVa  or  IVc,  and  there  were  two  each  of  the  IVg  and  V  elements),  and  two
were  nontypable.  The  genes  for  Panton-Valentine  leukocidin  (luk-PV)  were  detected
in  5.4%  of  the  study  isolates.  A  tst-positive,  CC22-MRSA-SCCmecIVa clone  (spa  type
t223)  was  identiﬁed  as  the  dominant  MRSA  lineage  among  the  nasal  carriage  iso-
lates  from  both  HCWs  and  other  individuals  (adults  and  children)  in  the  community.
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These  ﬁndings  provide  important  information  for  public  health  personnel  for  the  for-
mulation  of  effective  infection  prevention  and  control  strategies.  Studies  to  further
our  understanding  of  the  distribution,  pathogenicity,  transmissibility  and  ﬁtness  of
this  lineage  would  be  prudent.
©  2014  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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Cambridge, UK)  and  incubated  at  35 ◦C  for  24—72  h.
Presumptive  identiﬁcations  of  S.  aureus  were  based
on colony  morphology,  Gram  staining,  and  pos-Ltd.  All  rights  reserved.
ntroduction
ethicillin-resistant  Staphylococcus  aureus  (MRSA)
as long  been  recognized  as  a  major  nosocomial
athogen that  is  associated  with  severe  morbid-
ty and  mortality  [1].  Worldwide,  MRSA  infections
nd outbreaks  have  become  an  increasing  problem
ot only  in  healthcare  but  also  in  community  sett-
ngs [2].  Studies  from  various  countries  have  sought
o establish  the  nasal  carriage  rate  of  MRSA  in  the
ommunity.  The  ﬁgures  vary  widely  across  the  dif-
erent locations  and  populations  that  have  been
urveyed.  Published  data  show  the  nasal  carriage
ates  of  MRSA  in  Europe  and  the  USA  range  from
0.1% to  2.5%,  and  rates  up  to  10.5%  have  been
eported in  Africa  [3—8]. In  countries  in  the  Middle
ast (including  Saudi  Arabia,  Kuwait,  Lebanon  and
alestine),  0—13.2%  MRSA  nasal  carriage  rates  have
een observed  [9—14].  Studies  in  Jordan  suggest
igh MRSA  carriage  rates  of  7.5—19%  among  healthy
ndividuals  [15,16]. An  additional  concern  is  that  a
-year study  (2003—2005)  reported  an  MRSA  rate
f 56%  among  invasive  isolates  of  S.  aureus  from
ultiple  medical  centers  in  Jordan  [17].  Another
tudy  from  Jordan  [18]  indicated  that  of  the  232
. aureus  isolates  recovered  from  diverse  clinical
amples (abscesses,  wounds,  skin  infections,  blood
nd nasal  swabs),  62%  were  MRSA.
An understanding  of  the  molecular  epidemiol-
gy of  MRSA  is  crucial  for  the  formulation  and
mplementation of  appropriate  infection  preven-
ion and  control  measures  [19,20].  Despite  the
igh MRSA  rates,  few  reports  have  been  published
n the  molecular  epidemiology  of  MRSA  in  Jordan
16,21,22].  To  our  knowledge,  a  detailed  analysis  of
he nasal  strains  of  MRSA  that  occur  in  healthcare
nd community  settings  in  Jordan  has  not  been  pub-
ished. The  objectives  of  the  current  study  were  to
stablish  the  prevalence  and  phenotypic  and  geno-
ypic characteristics  of  MRSA  from  nasal  swabs  from
CWs and  other  healthy  individuals  (adults  and  chil-
ren) in  southern  Jordan.
i
(
iaterial and methods
tudy design and sample collection
he  sample  size  of  the  current  study  was  calcu-
ated using  Kish’s  formula  for  cross-sectional  studies
23]  based  on  MRSA  prevalences  of  5.8%,  7.5%
nd 13%  [15,21,24]  in  HCWs,  adults  and  children,
espectively, in  Jordan.  The  minimum  sample  sizes
equired  were  84  samples  from  HCWs,  107  samples
rom  adults  and  174  samples  from  children.  The
andomly  collected  samples  examined  in  this  study
297, 141  and  278  from  HCWs,  adults  and  children,
espectively) exceeded  these  ﬁgures.
Between  May  2011  and  April  2012,  non-duplicate
asal swabs  were  collected  from  the  study  popula-
ion. Written  informed  consent  and  a questionnaire
bout general  information  and  speciﬁc  risk  fac-
ors for  MRSA  carriage  were  obtained  from  each
articipant  or,  in  the  cases  of  the  children,  their
arents  or  guardians.  The  ethics  and  scientiﬁc
ommittee of  the  faculty  of  Medicine,  Mu’tah  Uni-
ersity approved  this  study.  All  HCWs  (medical
octors, nurses,  technicians,  domestic  and  admin-
strative  staff)  were  screened  while  working  in
he nursery,  maternity,  pediatric,  medical,  surgery
nd intensive  care  wards  of  Alkarak  governmental
ospital in  Jordan.  No  MRSA  outbreaks  were  appar-
nt during  the  sampling  period.  All  other  adults
nd children  were  randomly  selected  from  Alka-
ak province  (population  of  249,100  inhabitants
n 2012).  Nasal  swabs  were  immersed  in  nutri-
nt broth  (Oxoid,  Cambridge,  UK)  containing  5%
aCl and  incubated  for  3  h  at  37 ◦C.  Each  broth
as subcultured  on  mannitol  salt  agar  (Oxoid,tive catalase  and  slide  agglutination  reactions
bioMérieux, Marcy  l’Etoile,  France).  The  MRSA
solates  were  identiﬁed  by  disk  diffusion  using
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1  g  oxacillin  and  30  g cefoxitin  discs  in  accor-
dance with  the  Clinical  and  Laboratory  Standards
Institute (CLSI)  guidelines  [25]. Presumptive  MRSA
samples were  then  forwarded  to  the  Antimicrobial
Resistance and  Healthcare  Associated  Infections
(AMRHAI) Reference  Unit  (Public  Health  England,
Colindale, London)  for  further  characterization.
Antibiotic susceptibility testing
The  minimum  inhibitory  concentrations  (MICs)
of antibiotics  were  determined  by  agar  dilution
(British Society  for  Antimicrobial  Chemotherapy
method, BSAC  [26]).  The  following  antimicrobials
were tested:  vancomycin,  mupirocin,  gentamicin,
rifampicin, daptomycin,  teicoplanin,  linezolid,
erythromycin, tetracycline,  clindamycin,  fucidin,
and ciproﬂoxacin.
PCR-based detection of virulence and
resistance genes
All  study  isolates  were  examined  with  real-time
multiplex PCR  [27]  to  detect  the  thermonucle-
ase gene  (nuc),  methicillin  resistance  genes  (mecA
and mecC),  and  the  Panton-Valentine  leukocidin
gene (luk-PV).  A  total  of  29  representative  isolates
(including  at  least  one  of  each  spa  type)  were  sub-
jected  to  multiplex  PCR  [28]  to  detect  the  genes
encoding the  following:  enterotoxins  A-E  and  G-J
(sea-see and  seg-sej),  toxic  shock  syndrome  toxin-1
(tst), and  exfoliative  toxins  A,  B  and  D  (eta,  etb  and
etd). The  characterizations  of  the  staphylococcal
cassette chromosome  mec  (SCCmec)  elements  were
performed  on  all  isolates  according  to  the  protocol
described  by  Milheiric¸o  [29].
Spa typing
Spa  typing  was  performed  as  previously  described
[30].  Multi-locus  sequence  type  clonal  complex
(MLST-CC) assignments  were  inferred  based  on
spa typing  data  and  by  reference  to  the  spa
server (http://spa.ridom.de/mlst.shtml)  and  MLST
database  (http://saureus.mlst.net).
Results
Of  the  716  nasal  swabs  collected,  56  (7.8%)  yielded
MRSA  (Table  1).  The  MRSA  nasal  carriage  rates  of  the
HCWs, other  adults  and  children  were  10.1%,  4.3%
and 7.2%,  respectively.  Antibiotic  exposure  and
occupation  were  signiﬁcant  risk  factors  for  MRSA
nasal carriage  among  the  healthy  adults  and  HCWs,
g
l
a
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espectively  (Table  1).  All  MRSA  isolates  were  mecA
ositive,  and  mecC-MRSA  were  not  detected.  The
olecular  characterization  data  and  antibiotic  sus-
eptibility proﬁles  are  summarized  in  Table  2.
he majority  of  MRSA  isolates  harbored  SCCmec
ype  IV;  42  (75%)  encoded  SCCmecIVa,  10  (17.8%)
ncoded SCCmecIVc,  one  harbored  SCCmecIVg  and
ne harbored  SCCmecV.  Two  isolates  were  SCCmec
on-typable.  A  total  of  17  different  spa  types  of
arying toxin  gene  compositions  that  belonged  to
ight diverse  CCs  were  identiﬁed  (i.e.,  CC1,  CC5,
C15, CC22,  CC30,  CC45,  CC80  and  CC97).  Over-
ll, spa  types  t223  (n  =  22,  39%)  and  t386  (n  =  8,
4%), which  belong  to  CC22  and  CC1,  respectively,
ere predominant.  Resistance  to  the  following
ntimicrobials was  noted:  oxacillin  (100%),  eryth-
omycin  (42.8%),  tetracycline  (37.5%),  clindamycin
5.3%), fucidin  (5.3%),  and  ciproﬂoxacin  (3.5%).
ll MRSA  isolates  were  susceptible  to  vancomycin,
upirocin, gentamicin,  rifampicin,  daptomycin,
eicoplanin and  linezolid.
Three  MRSA  isolates  (5.4%)  were  luk-PV  positive;
wo of  these  were  from  adults  (spa  types  t044  and
803, which  belong  to  MLST-CC  80  and  15,  respec-
ively),  and  one  was  from  a  HCW  (spa  type  t044,
lso belonging  to  MLST-CC  80).
iscussion
revious  studies  have  provided  some  insight  into
he molecular  epidemiology  of  MRSA  in  the  Mid-
le East,  but  differing  results  have  been  reported
ccording to  the  cohorts  that  have  been  investi-
ated. For  example,  in  a  recent  study  conducted
y Sabri  [31], the  most  prevalent  MRSA  among  clin-
cal isolates  from  hospitalized  patients  in  three
rabian  countries  (Jordan,  Palestine  and  Iraq)  was
he pandemic  HA-MRSA  lineage  ST239-SCCmecIII
spa type  t932),  and  Khalil  [22]  reported  that  the
ost common  MRSA  recovered  from  the  nasal  and
tool samples  of  children  in  Jordan  was  the  ST80-IV
VL-positive CA-MRSA  clone.  In  contrast,  Al-Bakri
eported  that  SCCmecIV-MRSA  spa  types  t9519,  spa
ype t223  and  spa  type  t044  were  identiﬁed  among
6%, 14.7%  and  5.9%,  respectively,  of  all  MRSA  iso-
ates from  adults  in  Jordan  [16].
In the  present  study,  the  collective  data  revealed
hat the  overall  prevalence  of  the  nasal  carriage  of
RSA was  7.8%  (ranging  from  4.3%  in  adults  to  10.1%
n HCWs)  and  highlight  a  previously  unrecognized
enetic heterogeneity.  The  recovered  56  MRSA  iso-
ates were  belonged  to  eight  diverse  MLST-CCs
nd harbored  different  SCCmec  sub-types;  these
ndings  suggest  that  these  strains  had  multiple
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Table  1  Characteristics  of  MRSA  positive  individuals  versus  negatives  by  study  group.
Study  group  Demographic  data  Total  MRSA-positive  Percentage  (%)  P  valuea
HCWs  (n  =  297) Gender  0.52
Male  125  11  8.8
Female  172  19  11
Age  (years)  0.13
20—24 35  1  2.8
25—50 262  29  11
Occupation  0.002‡
Nurse  95  17  17.8
Othersb 202  13  6.4
Healthy  adults  (n  =  141) Gender  0.64
Male  60  2  3.3
Female  81  4  4.9
Age  (years) 0.33
20—24 115  4  3.4
25—50 26  2  7.6
Antibiotic  exposure <0.0001‡
Yes 19 5  26.3
No  122  1  0.8
Healthy  children  (n  =  278) Gender  0.13
Male  136  13  9.5
Female  142  7  4.9
Age  (years)  0.16
6—11  168  15  8.9
12—18  110  5  4.5
a P values for each category refer to comparison of MRSA positives versus negatives.
b Medical doctors, nurses, technicians, domestic and administrative staff.
‡ Signiﬁcant P value < 0.05.
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Urigins.  The  majority  of  the  MRSA  isolates  (54;
6.4%) harbored  the  smaller  SCCmec  elements  of
CCmecIV or  V  (2  were  non-typable).  The  follow-
ng two  major  clones  were  identiﬁed:  CC22-IVa  (spa
ypes t223,  t309  and  t6397),  and  CC1-IVa  (spa  types
386 and  t693).  These  clones  were  variously  resis-
ant to  erythromycin,  tetracycline,  clindamycin
nd/or ciproﬂoxacin.  Interestingly,  both  lineages
re among  the  most  common  MRSA  isolates  that
re identiﬁed  in  screening  samples  from  children
n Jordan  [22].  Data  from  Jordan  [16]  and  neigh-
oring countries  (i.e.,  namely  Palestine,  Lebanon
nd Saudi  Arabia)  also  revealed  that  SCCmecIV  is
ommonly  identiﬁed  in  nasal  and  clinical  MRSA  iso-
ates [14,31—33]. In  the  study  published  recently
y Al-Bakri,  spa  type  t223  was  found  to  be  the  sec-
nd most  common  type  in  Jordanian  adults  [16].
oreover,  the  ST22-MRSA-IVa  clone  (spa  t223)  is
ominant  in  Gaza  Strip  and  accounts  for  64%  of
he MRSA  in  healthy  children  and  their  parents
12].  Importantly,  although  this  clone  belongs  to
he same  MLST-CC  as  the  pandemic  healthcare-
ssociated EMRSA-15  strain,  it  differs  in  SCCmec
ype  (IVa  versus  IVh)  and  tst  status,  which  is
t
m
h
Tuggestive  of  different  epidemiologies  and  evolu-
ionary pathways  [34].
In accordance  with  previous  reports,  entero-
oxin genes  were  commonly  detected  in  the  study
solates  [35,36]. In  contrast,  the  prevalence  of
he PVL  genes  was  low.  Only  three  MRSA  isolates
5.4%) encoded  the  PVL  genes;  two  (t044)  of  these
elonged  to  the  so-called  European  clone  of  CA-
RSA and  were  recovered  from  adults  (one  of  whom
as a  HCW).  These  ﬁnding  parallel  those  of Al-Bakri
16]  who  found  only  two  PVL-positive  MRSA  isolates,
oth  of  which  belonged  to  spa  type  t044.  These
esults also  mirror  those  of  Biber  [12]  who  found
hat ST80-IV  was  the  dominant  PVL-MRSA  strain  in
ealthy children  and  their  parents  throughout  the
aza Strip.  Conversely,  Khalil  [22]  observed  that
4% of  the  MRSA  from  nasal  and  stool  samples  from
hildren up  to  one  year  of  age  who  attended  Jordan
niversity Hospital  in  Amman  were  PVL-positive.
Interestingly,  tst  positive  ST22-MRSA-IVa  spa223 was  found  to  be  the  predominant  non-
ultiresistant lineage  in  the  nasal  swabs  from  500
ealthy preschool  children  in  Palermo,  Italy  [37].
he same  MRSA  clone  was  prevalent  in  the  neonatal
94
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Table  2  Phenotypic  and  genotypic  characteristics  of  MRSA  isolates.
Sources of
MRSA (#)
Spa type (#) Spa  repeat succession MLST-CC SCCmec
type
Toxin  gene proﬁle
(no. isolates tested)
Resistant toa
Erythro-mycin Tetracy-cline Clinda-mycin Ciproﬂo-xacin Fusidic
acid
Children (20) t012 (1) 15-12-16-02-16-02-25-17-24-24 30 IVc seg,  sei,  tst S S S S  S
t021 (2) 15-12-16-02-16-02-25-17-24 30 IVg, IVa seg,  sei (n = 1) R S S S  S
t214 (3) 26-23-17-34-17-20-17-12-17-16-16 5 IVa seg,  sei (n = 1) S S S S  S
t223 (9) 26-23-13-23-05-17-25-17-25-16-28 22 IVa seg,  sei,  tst (n = 2) [R] [R] S S  S
t253 (1) 15-12-16-02-16-02-25-17-24-24-24-24 30 IVc seg,  sei,  tst S  S S S  S
t386 (2) 07-23-13 1 IVa seg,  seh,  sei (n = 1) R  R S S  S
t6397 (1) 26-13-23-05-17-25-17-25-16-28 22 IVa seg,  sei,  tst R  R S S  S
t790 (1) 26-23-13-23-31-29-17-25-17-25-16-28 22 IVa sec,  seg,  sei, R R S S  S
Adults (6) t044 (1) 07-23-12-34-34-33-34 80 IVc seh,  etd,  luk-PV S  R S S  R
t1234 (1) 07-23-12-12-34-34-34-33-34 97 NT — S R S S  S
t1651 (2) 08-16-02-43-34-16-02-17-16 30 IVc sec,  tst (n = 1) S S S S  S
t223 (1) 26-23-13-23-05-17-25-17-25-16-28 22 IVa ND S R S S  S
t803 (1) 07-23-02-12-23 15 NT etd,  luk-PV S S S S  S
HCWs (30) t018 (2) 15-12-16-02-16-02-25-17-24-24-24 30 IVc seg,  sei,  tst (n = 2) S S S S  S
t012 (1) 15-12-16-02-16-02-25-17-24-24 30 IVc tst S S S S  S
t021 (2) 15-12-16-02-16-02-25-17-24 30 IVa, V seg,  sei (n = 1) S S S S  S
t044 (1) 07-23-12-34-34-33-34 80 IVc seh,  etd,  luk-PV S R S S  R
t10683 (2) 35-17-34-17-20-17-12-17-16-16 5 IVa [sed], seg,  sei (n = 2) [R] S S S  S
t223 (12) 26-23-13-23-05-17-25-17-25-16-28 22 IVa seg,  sei,  tst [R] [R] S S  S
t309 (2) 26-23-05-17-25-17-25-16-28 22 IVa seg,  sei,  tst R R R S  R
t370 (1) 09-34-17-34-16-34 45 IVc seg,  sei R S S S  S
t386 (6) 07-23-13 1 IVa seh (n = 2) R [R] [R] [R] S
t693 (1) 7 1 IVa seh R R S S  S
MLST-CC, multilocus sequence type clonal-complex; SCCmec, staphylococcal cassette chromosome mec; luk-PV,  Panton-Valentine leukocidin genes; tst,  toxic shock syndrome toxin-1
gene; etd, exfoliative toxin D gene; sec, sed, seg,  she and sei,  genes for enterotoxin genes C, D, G, H and I. All isolates tested negative for enterotoxin genes A, B, E, J and exfoliative
toxin genes A and B. NT, non-typable; ND, not done; results in brackets [] were variable; —, negative for all toxin genes tested; R, resistant; S, susceptible.
a All isolates were susceptible to vancomycin, mupirocin, gentamicin, rifampicin, daptomycin, teicoplanin and linezolid.
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ntensive  care  unit  (NICU)  and  had  a  coloniza-
ion rate  of  88.8%  among  infants  in  Palermo,  Italy
38].  Given  these  ﬁndings,  it  seems  likely  that
his lineage  is  more  widely  distributed  than  cur-
ently  appreciated.  Further  studies  are  necessary
o assess  the  risk  factors  for  harboring  and  dis-
eminating  this  clone  across  a  range  of  community
nd hospital  settings.  In  our  study  population,  risk
actors, such  as  antibiotic  exposure  and  occupa-
ion,  were  associated  with  increased  MRSA  nasal
arriage. Uncontrolled  antibiotic  consumption  has
een suggested  to  facilitate  and  increase  nasal
RSA colonization  [39]. Similarly,  among  HCWs,
he nursing  occupation  was  signiﬁcantly  associated
ith MRSA  nasal  colonization,  which  is  most  likely
ttributable  to  patient  contact.
The MRSA  isolates  recovered  in  this  study
ere susceptible  to  a  broad  range  of  agents,
nd none  were  multi-resistant.  The  most  com-
only encountered  resistance  was  to  erythromycin
42.1%), followed  by  tetracycline  (36.8%),  which
ikely reﬂects  the  widespread  use  of  these  antibi-
tics in  Jordan.  MRSA  isolates  harboring  the  larger
CCmec  types  (I,  II,  and  III),  which  are  often
ssociated with  HA-MRSA  strains,  were  absent
n our  study.  Although  MRSA  isolates  with  the
arger SCCmec  elements  have  remained  preva-
ent in  the  healthcare  environment,  those  with
maller  SCCmec  types  are  considered  to  be  ‘‘ﬁtter’’
nd have  proven  to  be  successful  both  in  com-
unity and  healthcare  settings.  The  inﬁltration
f MRSA  isolates  with  ‘‘community-like’’  pheno-
ypes/genotypes  into  hospitals  may  result  in  strains
uch as  those  identiﬁed  herein  becoming  estab-
ished as  nosocomial  pathogens  in  addition  to  the
xtant HA-MRSA.  Indeed,  such  inﬁltration  has  pre-
iously been  documented  in  some  countries;  for
xample,  the  PVL-positive  USA300  clone  of  CA-
RSA dominates  in  some  hospitals  in  North  America
nd is  responsible  for  approximately  70%  of  hos-
ital acquired  infections  [40].  Similarly,  ST59-IV
as become  an  important  nosocomial  pathogen  in
ospitals in  Taiwan  [41]. Given  these  ﬁndings,  the
ossibility  of  clones  with  smaller  SCCmec  types,
uch as  those  identiﬁed  in  the  present  study,
merging as  successful  pathogens  in  healthcare  and
ommunity environments  in  Jordan  and  elsewhere
s a cause  for  increasing  concern.
This study  highlights  the  value  of  molecular  typ-
ng in  the  monitoring  of  trends  in  the  emergence,
pread and  epidemiology  of  MRSA  strains  nationally
nd internationally.  In  view  of  the  high  MRSA  rates
ssociated  with  carriage  and  infection  in  healthcare
nd community  settings  in  Jordan,  these  results
upport  the  need  for  MRSA  screening  policies  to
dentify  carriers  and  subsequent  referral  to  localJordan  95
nfection  prevention  and  control  teams  for  decolo-
ization,  as  has  previously  been  recommended  [42].
ctively managed  antibiotic  policies  and  steward-
hip in  combination  with  surveillance  are  required
o prevent  both  further  increases  in  MRSA  rates  and
he emergence  of  multidrug-resistant  MRSA  strains.
urther  studies  are  required  to  compare  the  epi-
emiologies  of  MRSA  clones  across  the  Middle  East
ith those  of  other  geographical  regions  across
he world.  Studies  to  further  our  understanding  of
he distribution,  pathogenicity,  transmissibility  and
tness of  the  tst-positive  ST22-MRSA-IVa  lineage
ould  also  be  prudent.
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